Feedback / Questions
ALE.C04 - Alentis Therap
https://www.businesswire.com/news/home/20230614534402/en/Alentis-Therapeutics-Receives-IND-Clearance-from-FDA-for-ALE.C04-for-the-Treatment-of-CLDN1-Tumors
Jun 14, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next